Vixotrigine

DB11706InvestigationalSmall molecule

Vixotrigine has been investigated for the treatment of Bipolar Disorder and Bipolar Depression.

Mechanism: Pharmacologically active on Sodium channel protein type 9 subunit alpha
Curator reviewed
Formula / weight: C₁₈H₁₉FN₂O₂ · 314.36 g/mol (avg)
Also known as: Raxatrigine
Code names: BIIB074 · CNV-1014802 · GSK-1014802

Resolves to

Compound

Structure

InChIKeyJESCETIFNOFKEU-SJORKVTESA-NSMILESNC(=O)[C@@H]1CC[C@@H](N1)C1=CC=C(OCC2=CC=CC=C2F)C=C1

Targets

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

17Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Vixotrigine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.